首頁 › 神經膠質瘤 › 賓夕法尼亞州 › Philadelphia
Philadelphia, PA 的 神經膠質瘤 臨床試驗
16 項針對 神經膠質瘤 的研究正在 Philadelphia（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
招募中1/2 期
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · 距離 25 英里
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
招募中2 期
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
招募中1/2 期
- Children's Hospital of Philadelphia-Center for Childhood Cancer Research, Philadelphia
Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
招募中早期第 1 期
- The Children s Hospital of Philadelphia, Philadelphia
Targeted Pediatric High-Grade Glioma Therapy
招募中觀察性研究
- Children's Hospital of Philadelphia, Philadelphia
Study of Olutasidenib and Temozolomide in HGG
招募中2 期
- Children's Hospital of Philadelphia, Philadelphia
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
招募中3 期
- Thomas Jefferson University Hospital, Philadelphia
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
招募中2 期
- Children's Hospital of Philadelphia, Philadelphia
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
招募中1 期
- Children's Hospital of Philadelphia, Philadelphia
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
招募中2 期
- Thomas Jefferson University, Philadelphia
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
招募中1/2 期
- Children's Hospital of Philadelphia, Philadelphia
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
招募中早期第 1 期歡迎健康志工
- Children's Hospital of Philadelphia, Philadelphia
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
招募中2 期
- Children's Hospital of Philadelphia, Philadelphia
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
招募中早期第 1 期
- Children's Hospital of Philadelphia, Philadelphia
All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma
招募中2 期
- University of Pennsylvania, Philadelphia
18F-Fluciclovine PET-MRI in High-grade Glioma
招募中早期第 1 期
- Children's Hospital of Philadelphia, Philadelphia
其他城市的 神經膠質瘤 試驗
- New York City, NY25 項研究
- Houston, TX23 項研究
- Boston, MA20 項研究
- Washington, DC19 項研究
- Columbus, OH15 項研究
- Miami, FL15 項研究
- San Francisco, CA14 項研究
- Chicago, IL13 項研究
- Durham, NC12 項研究
- Seattle, WA11 項研究
- St. Louis, MO10 項研究
- Aurora, CO10 項研究
Philadelphia 的其他研究
- 癌症（所有類型）59 項研究
- 乳癌56 項研究
- 非小細胞肺癌51 項研究
- 轉移性癌症46 項研究
- 前列腺癌44 項研究
- 大腸直腸癌44 項研究
- 卵巢癌44 項研究
- 肺癌36 項研究
- 急性髓系白血病34 項研究
- 心臟衰竭31 項研究
- 子宮內膜癌28 項研究
- 憂鬱症26 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。